InvestorsHub Logo

go_wamu

04/16/21 11:59 PM

#38441 RE: Tiger Money #38438

IMO it would be a big mistake to sell RLFTF now.
Relief Therapeutics are not lazy Europeans. But they wont be fooled, if others try to buy their patent piece by piece. The cooperation with AdVita is now so successful that they care about the result of the clinical evaluation of their new study only and it doesn't matter whether NeuroRx is successful in case of EUA or not.
Relief originally funded the NeuroRx costs, but now it's game over. It is now up to Big Rock Partners whether they continue to show interest in Zyesami.